Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new page revision tag v3.6.6 was added and the previous v3.6.5 revision was removed. This indicates the page has been updated to a newer version.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision marker was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's documentation or version history.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 to reflect a newer version of the page/template. This is a metadata change and does not alter the study details or user-facing content.SummaryDifference0.1%

- Check58 days agoChange DetectedA new endpoint, ‘Cumulative Percentage of Patients Remaining Distant Metastases-Free/Alive at 1yr and 2yrs After Initial Treatment,’ was added on 2026-07-16, and the previous endpoint ‘Percentage of Participants With Distant Metastases-free Survival’ was removed on 2026-06-16, reflecting a refinement of the distant metastases–free survival measure.SummaryDifference0.3%

- Check72 days agoChange DetectedThe page's revision tag was updated to version v3.6.3, representing a small update to the page's template or backend tracking rather than any substantive change to the study details.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor backend/content-management update. No study information or user-facing content is affected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.